Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities
Authors:
- 1 July 2011
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1807 (7) , 819-828
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NS 36157)
This publication has 32 references indexed in Scilit:
- Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cellsNeurobiology of Disease, 2009
- Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: Implications for Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
- Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine‐associated diseasesJournal of Neurochemistry, 2004
- Neurotoxicity of Endogenous CysteinylcatecholsExperimental Neurology, 1997
- Dopamine Neurotoxicity: Inhibition of Mitochondrial RespirationJournal of Neurochemistry, 1995
- Identification of Catechol‐Protein Conjugates in Neostriatal Slices Incubated with [3H]Dopamine: Impact of Ascorbic Acid and GlutathioneJournal of Neurochemistry, 1994
- An immunohistochemical study on α‐ketoglutarate dehydrogenase complex in Parkinson's diseaseAnnals of Neurology, 1994
- An Evaluation of the Measurement of the Activities of Complexes I-IV in the Respiratory Chain of Human Skeletal Muscle MitochondriaBiochemical Medicine and Metabolic Biology, 1994
- Mitochondrial Complex I Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Detection of 5-S-cysteinyldopamine in human brainJournal of Neural Transmission, 1985